OptimizeRx Corp — Director's Dealing 2021

Jan 29, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: OptimizeRx Corp (OPRX)
CIK: 0001448431
Period of Report: 2021-01-29

Reporting Person: BAKER DOUGLAS P (CHIEF FINANCIAL OFFICER)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-01-29	Common Stock	S	5032	$47.25	Disposed	85902	Direct
2021-01-29	Common Stock	M	4315	$7.51	Acquired	90217	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-01-29	Stock Option	$7.51	M	4315	Disposed	2025-03-11	Common Stock (4315)	Direct

Footnotes

F1: These shares sold pursuant to a plan of disposition adopted on September 22, 2020 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. This sale completes the plan.